SCHEMBL5140180

SCHEMBL5140180

CCOC(=O)c1cc(C)nc2c1ncn2Cc1ccc(OC)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 3/20 0.46
ALDH1A1 P00352 3/20 0.46
GAA P10253 3/20 0.46
KDM4E B2RXH2 2/20 0.46
HPGD P15428 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
USP2 O75604 1/20 0.46
GLA P06280 1/20 0.46
MAPK1 P28482 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ADORA2A P29274 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
YTHDC1 Q96MU7 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1668945 0.87 NR3C1 (0.48) NR3C1ALDH1A1GAAKDM4EHPGD
SCHEMBL1665638 0.79 MEN1 (0.50) NR3C1ALDH1A1GAAHPGDADORA2A
SCHEMBL15282273 0.77 NR3C1 (0.52) NR3C1ALDH1A1GAAKDM4EHPGD
SCHEMBL21883541 0.74 ADORA2A (0.44) NR3C1ALDH1A1GAAKDM4EHPGD
SCHEMBL30496460 0.74 ADORA2A (0.44) NR3C1ALDH1A1GAAKDM4EHPGD
SCHEMBL843514 0.73 TUBB4A (0.49) ALDH1A1GAAKDM4EHPGDNPSR1
SCHEMBL14441143 0.72 MEN1 (0.52) NR3C1ALDH1A1GAAKDM4EHPGD
SCHEMBL12429215 0.71 TP53 (0.49) ALDH1A1GAAKDM4EHPGDNPSR1
SCHEMBL14441142 0.71 HSP90AB1 (0.54) NR3C1HPGDADORA2AMEN1KMT2A
SCHEMBL1003088 0.70 GAA (0.54) NR3C1ALDH1A1GAAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891042-B1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA SA (BE) 2013-10-02 EP disclosed
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP disclosed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed